相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improving prognostic assignment in older adults with multiple myeloma using acquired genetic features, clonal hemopoiesis and telomere length
Eileen M. Boyle et al.
LEUKEMIA (2022)
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma
Jordane Demonchy et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
The Role of the Gut Microbiome in Pathogenesis, Biology, and Treatment of Plasma Cell Dyscrasias
Marcin Jasinski et al.
FRONTIERS IN ONCOLOGY (2021)
Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
Sarah Bird et al.
LANCET HAEMATOLOGY (2021)
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care
Faouzi Djebbari et al.
HAEMATOLOGICA (2020)
Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.
Nikhil C. Munshi et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Persistent Poverty and Cancer Mortality Rates: An Analysis of County-Level Poverty Designations
Jennifer L. Moss et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
Shaji K. Kumar et al.
LANCET ONCOLOGY (2020)
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee et al.
LANCET ONCOLOGY (2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Ajai Chari et al.
BLOOD (2020)
LMP1 expression in bone marrow trephines of patients with multiple myeloma confers a survival advantage
Sheerien Rajput et al.
LEUKEMIA & LYMPHOMA (2019)
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma
Hareth Nahi et al.
PLOS ONE (2019)
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
Mohamad Mohty et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
T. Facon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis
Ashleigh McGirr et al.
VACCINE (2019)
Response to pneumococcal vaccination in multiple myeloma
Loic Renaud et al.
CANCER MEDICINE (2019)
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial
Eileen M. Boyle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study
Philippe Moreau et al.
LANCET (2019)
Analysis of Intestinal Microbiome in Multiple Myeloma Reveals Progressive Dysbiosis Compared to MGUS and Healthy Individuals
Crystal Antoine Pepeljugoski et al.
BLOOD (2019)
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
Corrado Girmenia et al.
BLOOD REVIEWS (2019)
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
Mark T. Drayson et al.
LANCET ONCOLOGY (2019)
Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
Matthew J. Pianko et al.
BLOOD ADVANCES (2019)
Multiple Myeloma: What Do We Do About Immunodeficiency?
Linrong Li et al.
JOURNAL OF CANCER (2019)
CAR T cell therapy for multiple myeloma: where are we now and where are we headed?
Arnab Ghosh et al.
LEUKEMIA & LYMPHOMA (2018)
Plasma cell diseases and organ transplant: A comprehensive review
Andrew J. Cowan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
Immunomodulatory drugs and the risk of serious infection in multiple myeloma: systematic review and meta-analysis of randomized and observational studies
Min Chen et al.
ANNALS OF HEMATOLOGY (2018)
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
Vancheswaran Gopalakrishnan et al.
CANCER CELL (2018)
Early mortality in elderly patients undergoing treatment for multiple myeloma in real-world practice
Jun Xia et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial
Drew J. Winston et al.
LANCET (2018)
A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial
Charles Dumontet et al.
LEUKEMIA (2018)
Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression
Arianna Calcinotto et al.
NATURE COMMUNICATIONS (2018)
Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
Joshua A. Hill et al.
BLOOD (2018)
Epidemiology of bloodstream infections in patients with myeloma receiving current era therapy
Benjamin W. Teh et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2017)
Epstein-Barr virus infection is associated to patients with multiple myeloma and monoclonal gammopathy of undetermined significance
Giuseppe Mameli et al.
LEUKEMIA & LYMPHOMA (2017)
Lenalidomide and the risk of serious infection in patients with multiple myeloma: a systematic review and meta-analysis
Li Ying et al.
ONCOTARGET (2017)
Monoclonal IgG in MGUS and multiple myeloma targets infectious pathogens
Adrien Bosseboeuf et al.
JCI INSIGHT (2017)
Clinical and Serologic Responses After a Two-dose Series of High-dose Influenza Vaccine in Plasma Cell Disorders: A Prospective, Single-arm Trial
Andrew R. Branagan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
VTD is superior to VCD prior to intensive therapy in multiple myeloma: results of the prospective IFM2013-04 trial
Philippe Moreau et al.
BLOOD (2016)
The T Cell in Myeloma
Douglas Joshua et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma
Shiny Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Common Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort Study
Laurence Fardet et al.
PLOS MEDICINE (2016)
Influenza and Pneumococcal Vaccination in Hematological Malignancies: a Systematic Review of Efficacy, Effectiveness, and Safety
Giuseppe La Torre et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2016)
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation
Michael J. Satlin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy
Benjamin W. Teh et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization
Benjamin W. Teh et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2015)
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
Michael Hahn et al.
HAEMATOLOGICA (2015)
Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma
S. Park et al.
TRANSPLANT INFECTIOUS DISEASE (2015)
Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma
Michael Hahn et al.
HAEMATOLOGICA (2015)
Plasma cell numbers decrease in bone marrow of old patients
Theresa Pritz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies
Benjamin W. Teh et al.
HAEMATOLOGICA (2015)
Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients
Cecilie Blimark et al.
HAEMATOLOGICA (2015)
Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
Pierre Fillatre et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients
Quoc Truong et al.
ANNALS OF HEMATOLOGY (2014)
Changing treatment paradigms for patients with plasma cell myeloma: Impact upon immune determinants of infection
Benjamin W. Teh et al.
BLOOD REVIEWS (2014)
Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2014
M. A. Slavin et al.
INTERNAL MEDICINE JOURNAL (2014)
Effect of levofloxacin prophylaxis for prevention of severe infections in multiple myeloma patients receiving bortezomib-containing regimens
Sung-Hoon Jung et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma
Lotfi Benboubker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma
Sarah M. Tete et al.
FRONTIERS IN IMMUNOLOGY (2014)
Causes, consequences, and reversal of immune system aging
Encarnacion Montecino-Rodriguez et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Dendritic cell-mediated activation-induced cytidine deaminase (AID)-dependent induction of genomic instability in human myeloma
Srinivas Koduru et al.
BLOOD (2012)
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study
Sigurdur Y. Kristinsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The role of natural killer cells in immunity against multiple myeloma
James Godfrey et al.
LEUKEMIA & LYMPHOMA (2012)
Innate immunosenescence: Effect of aging on cells and receptors of the innate immune system in humans
Rafael Solana et al.
SEMINARS IN IMMUNOLOGY (2012)
Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications
Piers Blombery et al.
ANNALS OF HEMATOLOGY (2011)
Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial
Edward A. Stadtmauer et al.
BLOOD (2011)
Bortezomib plus dexamethasone versus reduced-dose bortezomib, thalidomide plus dexamethasone as induction treatment before autologous stem cell transplantation in newly diagnosed multiple myeloma
Philippe Moreau et al.
BLOOD (2011)
Infectious complications in patients with multiple myeloma treated with new drug combinations containing thalidomide
Massimo Offidani et al.
LEUKEMIA & LYMPHOMA (2011)
Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit
D. Collett et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia
Rekha Pal et al.
BLOOD (2010)
PROPHYLAXIS AGAINST INFECTIONS WITH INTRAVENOUS IMMUN0GLOBULINS IN MULTIPLE MYELOMA
Pellegrino Musto et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2009)
Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer
Anne-Marie Glenny et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Varicella-Zoster Virus Prophylaxis with Low-Dose Acyclovir in Patients with Multiple Myeloma Treated with Bortezomib
Ludek Pour et al.
CLINICAL LYMPHOMA & MYELOMA (2009)
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation
Veronique Erard et al.
BLOOD (2007)
CD4+T lymphocyte counts after autologous transplantation in multiple myeloma: A retrospective study
Marcus Gorschlueter et al.
LEUKEMIA & LYMPHOMA (2007)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma
Amelie Guihot et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Immune parameters in multiple myeloma patients:: Influence of treatment and correlation with opportunistic infections
Philipp Schuett et al.
LEUKEMIA & LYMPHOMA (2006)
The global health burden of infection -associated cancers in the year 2002
Donald Maxwell Parkin
INTERNATIONAL JOURNAL OF CANCER (2006)
An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital
LJ Worth et al.
BRITISH JOURNAL OF CANCER (2005)
Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy
D Eisen et al.
BONE MARROW TRANSPLANTATION (2003)
Rates of non-AIDS-defining infection before and cancers in people with HIV after AIDS diagnosis
AE Grulich et al.
AIDS (2002)
Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation
MC Dignani et al.
BONE MARROW TRANSPLANTATION (2002)
Late infections after blood progenitor cell transplantation in patients with multiple myeloma
H Steingrimsdottir et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Infectious complications after high-dose chemotherapy and autologous stem cell transplantation:: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors
G Reich et al.
BONE MARROW TRANSPLANTATION (2001)
Clinical relevance of age-related immune dysfunction
SC Castle
CLINICAL INFECTIOUS DISEASES (2000)
Epidemiology and unique aspects of aging and infectious diseases
TT Yoshikawa
CLINICAL INFECTIOUS DISEASES (2000)
Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: A European organization for research and treatment of cancer
O Lortholary et al.
CLINICAL INFECTIOUS DISEASES (2000)
分享论文
